CONFERENCE 2025
Program
September 12, 2025
Friday12:00 – 18:00REGISTRATION
13:00 – 13:30OFFICIAL OPENING
13:30 – 16:00
FIRST SCIENTIFIC SESSION
„From Science to Clinical Practice“
Moderator: Assoc. prof. Veselin Popov MD, PhD
13:30 – 13:50Perioperative treatment of early-stage lung cancer. Role of surgery. Dr Katrin Welcker MD, FEBTS, FECTS.
13:50 – 14:10Focal therapy for prostate cancer Prof. Alessandro Zucchi MD, PhD.
14:10 – 14:30Technologic Innovations in Oncologic Surgery Prof. Andreas Kirschniak MD, PhD.
14:30 – 14:50Separation surgery in metastatic spine tumors Prof. Cuneyt Temiz MD, PhD.
14:50 – 15:10Metabolic-hybrid SLN-SPECT-CT Mapping and PET-CT Staging for Treatment Tailoring in Breast Cancer Prof. Elena Piperkova, MD, PhD, DMSc.
15:10 – 15:30From Bench to Bedside: Innovative Hematologic Therapies as a Blueprint for Precision Oncology Prof. Veselina Goranova-Marinovа MD, PhD.
15:30 – 15:50Core principles of cardio-oncology care Prof. Maria Tokmakova MD, PhD.
15:50 – 16:00DISCUSSION PANEL
16:00 – 16:30COFFEE BREAK
16:30 – 18:15
„Innovations in Radiation Oncology“
16:30 – 17:15
Symposium by Meditel Healthcare
Experience on Radixact and Vision RT usage at Anadolu Medical Center and new developments – Prof. Hale Başak Çağlar
Reshaping Proton Therapy with 4th Generation Linac Size Mevion S250Fit – Gökay Çelik
Experience on Radixact and Vision RT usage at Anadolu Medical Center and new developments – Prof. Hale Başak Çağlar
Reshaping Proton Therapy with 4th Generation Linac Size Mevion S250Fit – Gökay Çelik
17:15 – 18:00
Symposium by Elekta
Elekta’s vision for Adaptive Therapy – Mrs. Veronica Dell’Acqua
Elekta’s vision for Adaptive Therapy – Mrs. Veronica Dell’Acqua
18:00 – 18:15
Symposium by Santis Medical Solutions
Cranial stereotactic radiosurgery /ZAP-X/ – Prof. Dr. Elitsa Encheva – Mitsova, MD, PhD
Cranial stereotactic radiosurgery /ZAP-X/ – Prof. Dr. Elitsa Encheva – Mitsova, MD, PhD
18:15 – 19:45
„Business Meets Clinical Practice“
18:15 – 18:30
Symposium by Servier
Moderator: Prof. Dr. Zh. Grudeva-Popova, MD, PhD Tibsovo – therapeutic innovation in AML and cholangiocarcinoma
Moderator: Prof. Dr. Zh. Grudeva-Popova, MD, PhD Tibsovo – therapeutic innovation in AML and cholangiocarcinoma
18:30 – 19:00
Symposium by Astra Zeneca
AMPLIFY – a new path in familiar waters – Dr. V. Graklanov, MD, PhD
Continued confidence with Calquence – Dr. A. Yordanov
A ray of hope: the role of radiotherapy in lung cancer – Assoc. Prof. Dr. V. Popov, MD, PhD
AMPLIFY – a new path in familiar waters – Dr. V. Graklanov, MD, PhD
Continued confidence with Calquence – Dr. A. Yordanov
A ray of hope: the role of radiotherapy in lung cancer – Assoc. Prof. Dr. V. Popov, MD, PhD
19:00 – 19:30
Symposium by Abbvie: Innovations in the treatment of CLL: fixed regimens and new perspectives
Do we know the ‘masks’ of CLL? – Assoc. Prof. Dr. I. Nenova, MD, PhD
Have we changed the therapeutic standard in CLL? – Dr. V. Graklanov, MD, PhD
Do we know the ‘masks’ of CLL? – Assoc. Prof. Dr. I. Nenova, MD, PhD
Have we changed the therapeutic standard in CLL? – Dr. V. Graklanov, MD, PhD
19:30 – 19:45
Symposium by Ewopharma
Managing adverse events of targeted therapy in an interdisciplinary team – the key to effective treatment – Dr. D. Tumbeva
Managing adverse events of targeted therapy in an interdisciplinary team – the key to effective treatment – Dr. D. Tumbeva
20:00 – 21:30WELCOME COCKTAIL
September 13, 2025
Saturday08:30 – 16:00REGISTRATION
09:00 – 10:30
SECOND SCIENTIFIC SESSION
„Interdisciplinary Perspectives – Discussion Panel“
Moderator: Prof. Dr. Zh. Grudeva-Popova, MD, PhD
09:00 – 09:20History of Bulgarian radiotherapy Prof. Dr. Tatyana Hadzhieva, MD, DSc
09:20 – 09:40First CRC screening in the country – where to now? Prof. Dr. Galina Kurteva, MD, PhD
09:40 – 10:00Robotic surgery in uro-oncology Assoc. Prof. Dr. Petar Antonov, MD, PhD
10:00 – 10:20Artificial intelligence in radiotherapy – a new reality Prof. Dr. Iglika Mihaylova, MD, PhD
10:20 – 10:30Discussion panel
10:30 – 11:00COFFEE BREAK
Digital poster session, foyer, 3rd floor
Digital poster session, foyer, 3rd floor
11:00 – 13:00
„Business Meets Clinical Practice“
11:00 – 11:55
Symposium by Swixx Biopharma „New trends in the treatment of LR-MDS“
Moderator: Assoc. Prof. Dr. A. Radinov, MD, PhD Challenges in the care of patients with LR-MDS – Assoc. Prof. Dr. I. Nenova, MD, PhD
How do we treat MDS today? What does the hematologist have in their arsenal? – Dr. K. Sapunarova, MD, PhD
From clinical trial data to real-world practice – Dr. P. Georgiev, MD, PhD
Panel discussion
Moderator: Assoc. Prof. Dr. A. Radinov, MD, PhD Challenges in the care of patients with LR-MDS – Assoc. Prof. Dr. I. Nenova, MD, PhD
How do we treat MDS today? What does the hematologist have in their arsenal? – Dr. K. Sapunarova, MD, PhD
From clinical trial data to real-world practice – Dr. P. Georgiev, MD, PhD
Panel discussion
11:55 – 12:35
Symposium by Pfizer „New treatment options for R/R multiple myeloma“
Moderator: Prof. Dr. Zh. Grudeva-Popova, MD, PhD Multiple myeloma then and now – Dr. A. Yordanov
Innovations in the treatment of multiple myeloma – Prof. Dr. V. Goranova, MD, PhD
Panel discussion
Moderator: Prof. Dr. Zh. Grudeva-Popova, MD, PhD Multiple myeloma then and now – Dr. A. Yordanov
Innovations in the treatment of multiple myeloma – Prof. Dr. V. Goranova, MD, PhD
Panel discussion
12:35 – 13:20
Symposium by Astellas Pharma „Latest achievements in oncology and hematology: our experience meets the world’s“
Moderator: Prof. Dr. Zh. Grudeva-Popova, MD, PhD EMBARK – the moment to start with Xtandi. Clinical case – Dr. G. Raycheva, MD, PhD
Optimizing the treatment of relapsed/refractory acute myeloid leukemia with FLT3 mutation – Dr. H. Ivanova, MD, PhD
Moderator: Prof. Dr. Zh. Grudeva-Popova, MD, PhD EMBARK – the moment to start with Xtandi. Clinical case – Dr. G. Raycheva, MD, PhD
Optimizing the treatment of relapsed/refractory acute myeloid leukemia with FLT3 mutation – Dr. H. Ivanova, MD, PhD
13:20 – 14:30LUNCH
Digital poster session, foyer, 3rd floor
Digital poster session, foyer, 3rd floor
14:30 – 16:00
THIRD SCIENTIFIC SESSION
„The Young Hopes in Oncology“
Moderator: Assoc. Prof. Dr. P. Antonov, MD, PhD
14:30 – 14:45Non-invasive diagnostic tests for urothelial bladder carcinoma – Dr. A. Belov
14:45 – 15:00NA(I)CT through the eyes of the surgeon – Dr. P. Uchikov, MD, PhD
15:00 – 15:15Markers for early renal damage in patients undergoing systemic antitumor drug therapy – Dr. N. Dimov
15:15 – 15:30Stereotactic radiosurgery with Cyberknife for prostate cancer: low toxicity and preserved quality of life – Dr. S. Pavlov
15:30 – 15:45Efficacy of malignant melanoma therapy with immune checkpoint inhibitors depending on primary localization and tumor biomarkers in patients from the Bulgarian population – Dr. A. Gerasimov
15:45 – 16:00Attitudes of general practitioners towards cervical cancer prevention: a qualitative study – Dr. G. Apostolova
16:00 – 16:30COFFEE BREAK
Digital poster session, foyer, 3rd floor
Digital poster session, foyer, 3rd floor
16:30 – 19:00
„Business Meets Clinical Practice“
16:30 – 17:00
Symposium by Roche
Moderator: Prof. Dr. V. Goranova-Marinova, MD, PhD Roche’s ongoing innovations in malignant diseases – Dr. T. Popova
Alecensa in the treatment of ALK (+) NSCLC – Dr. B. Nihat
Moderator: Prof. Dr. V. Goranova-Marinova, MD, PhD Roche’s ongoing innovations in malignant diseases – Dr. T. Popova
Alecensa in the treatment of ALK (+) NSCLC – Dr. B. Nihat
17:00 – 17:30
Symposium by Johnson & Johnson „Next-Generation Immunotherapy“
Innovative approaches in immuno-oncology: Current achievements and future directions – Prof. Dr. Zh. Grudeva-Popova, MD, PhD
Innovative approaches in immuno-oncology: Current achievements and future directions – Prof. Dr. Zh. Grudeva-Popova, MD, PhD
17:30 – 18:00
Symposium by Novartis „Treatment of chronic myeloid leukemia – a step forward“
Novartis in chronic myeloid leukemia – a history that transforms medicine – Dr. P. Georgiev, MD, PhD
Clinical case – Dr. Svilena Atanasova, MD, PhD
Novartis in chronic myeloid leukemia – a history that transforms medicine – Dr. P. Georgiev, MD, PhD
Clinical case – Dr. Svilena Atanasova, MD, PhD
18:00 – 18:30
Symposium by Takeda
Moderator: Assoc. Prof. Dr. V. Popov, MD, PhD Treatment efficacy and quality of life in patients with ALK+ NSCLC (Alunbrig) – Dr. K. Koynov
Fruzaqla (fruquintinib): a new paradigm in the treatment of mCRC – Prof. Dr. Zh. Grudeva-Popova, MD, PhD
Moderator: Assoc. Prof. Dr. V. Popov, MD, PhD Treatment efficacy and quality of life in patients with ALK+ NSCLC (Alunbrig) – Dr. K. Koynov
Fruzaqla (fruquintinib): a new paradigm in the treatment of mCRC – Prof. Dr. Zh. Grudeva-Popova, MD, PhD
20:00OFFICIAL DINNER – PRIMA HALL, IMPERIAL HOTEL
September 14, 2025
Sunday
09:00 – 10:30
FOURTH SCIENTIFIC SESSION
„Patient-Centered Approach and Innovations in Rare Benign Diseases“
Moderator: Prof. Dr. M. Spasova, MD, PhD
09:00 – 09:15Nuclear medicine and parathyroid glands – past, present and future Assoc. Prof. Dr. A. Botushanova, MD, PhD
09:15 – 09:30Robotic stereotactic radiosurgery for meningiomas Dr. G. Syuleyman
09:30 – 09:45Infrared thermography in breast cancer patients undergoing radiotherapy Dr. T. Aleksiev, MD, PhD
09:45 – 10:00When vanity becomes dangerous: the invisible risk of lymphoma after implants Dr. V. Graklanov, MD, PhD
10:00 – 10:15Diagnostic challenges in nuclear medicine – a clinical case of ovarian cystadenocarcinoma, highlighting the complementary value of 18F-FDG and 68Ga-FAPI PET/CT Dr. G. Karapetkova
10:15 – 10:30The role of nutrition in the integrated approach to cancer treatment Dr. G. Raycheva, MD, PhD
10:30 – 11:00COFFEE BREAK
11:00 – 13:30
„Business Meets Clinical Practice“
11:00 – 11:30
Symposium by Sobi „Challenges in the diagnosis and treatment of PNH and ITP“
Moderator – Prof. Dr. Zh. Grudeva-Popova, MD, PhD Aspaveli – the power of C3 inhibition – Prof. Dr. E. Spasov, MD, PhD
Doptelet – speed and reliability over time – Dr. I. Katsarska
Moderator – Prof. Dr. Zh. Grudeva-Popova, MD, PhD Aspaveli – the power of C3 inhibition – Prof. Dr. E. Spasov, MD, PhD
Doptelet – speed and reliability over time – Dr. I. Katsarska
11:30 – 12:00
Symposium by MSD
Choosing the right treatment for NSCLC patients: current therapeutic standard and future possibilities – Dr. G. Raycheva, MD, PhD
Choosing the right treatment for NSCLC patients: current therapeutic standard and future possibilities – Dr. G. Raycheva, MD, PhD
12:00 – 12:15
Symposium by Roche
Non-factor therapy for Hemophilia A (Hemlibra) – Prof. Dr. E. Spasov, MD, PhD
Non-factor therapy for Hemophilia A (Hemlibra) – Prof. Dr. E. Spasov, MD, PhD
12:15 – 12:30
Symposium by Amgen
Kyprolis – proven clinical efficacy in patients with R/R multiple myeloma – Dr. K. Sapunarova, MD, PhD
Kyprolis – proven clinical efficacy in patients with R/R multiple myeloma – Dr. K. Sapunarova, MD, PhD
12:30 – 12:45
Symposium by Teva
Lonquex (lipegfilgrastim) – a long-acting colony-stimulating factor with a unique molecular structure – Dr. E. Kalekanova
Lonquex (lipegfilgrastim) – a long-acting colony-stimulating factor with a unique molecular structure – Dr. E. Kalekanova
12:45 – 12:55
Symposium by Medison Pharma „Immunotherapy in immunosuppression“
How does Libtayo change the prognosis of secondary skin neoplasms? – Dr. D. Tumbeva
How does Libtayo change the prognosis of secondary skin neoplasms? – Dr. D. Tumbeva
13:00 – 13:15OFFICIAL CLOSING
Sponsors
PLATINUM SPONSORS
GOLD SPONSORS
SILVER SPONSORS
BRONZE SPONSORS
Gallery
×
![Enlarged Image]()
